| Mechanism of action of and resistance to quinolones A Fàbrega, S Madurga, E Giralt, J Vila Microbial biotechnology 2 (1), 40-61, 2009 | 550 | 2009 |
| Perspectives on NMR in drug discovery: a technique comes of age M Pellecchia, I Bertini, D Cowburn, C Dalvit, E Giralt, W Jahnke, TL James, ... Nature Reviews Drug Discovery 7 (9), 738-745, 2008 | 510 | 2008 |
| Chemical approaches to the synthesis of peptides and proteins P Lloyd-Williams, F Albericio, E Giralt CRC Press, 2020 | 496 | 2020 |
| Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery B Oller-Salvia, M Sánchez-Navarro, E Giralt, M Teixidó Chemical Society Reviews 45 (17), 4690-4707, 2016 | 436 | 2016 |
| Molecular recycling within amyloid fibrils N Carulla, GL Caddy, DR Hall, J Zurdo, M Gairí, M Feliz, E Giralt, ... Nature 436 (7050), 554-558, 2005 | 420 | 2005 |
| Nanoparticle-mediated local and remote manipulation of protein aggregation MJ Kogan, NG Bastus, R Amigo, D Grillo-Bosch, E Araya, A Turiel, ... Nano letters 6 (1), 110-115, 2006 | 413 | 2006 |
| Peptide and amide bond-containing dendrimers L Crespo, G Sanclimens, M Pons, E Giralt, M Royo, F Albericio Chemical reviews 105 (5), 1663-1682, 2005 | 390 | 2005 |
| Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan M Moreno, E Giralt Toxins 7 (4), 1126-1150, 2015 | 382 | 2015 |
| Atropisomerism, biphenyls and the Suzuki coupling: peptide antibioticsAbbreviations: Bn= benzyl; Boc= tert-butoxycarbonyl; dba= dibenzylideneacetone; Ddm= 4, 4 … P Lloyd-Williams, E Giralt Chemical Society Reviews 30 (3), 145-157, 2001 | 358 | 2001 |
| Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor R Prades, S Guerrero, E Araya, C Molina, E Salas, E Zurita, J Selva, ... Biomaterials 33 (29), 7194-7205, 2012 | 324 | 2012 |
| Convergent solid-phase peptide synthesis P Lloyd-Williams, F Albericio, E Giralt Tetrahedron 49 (48), 11065-11133, 1993 | 321 | 1993 |
| Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs J Vila, J Ruiz, F Marco, A Barcelo, P Goni, E Giralt, T Jimenez de Anta Antimicrobial agents and chemotherapy 38 (10), 2477-2479, 1994 | 314 | 1994 |
| Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines B Montaner, S Navarro, M Piqué, M Vilaseca, M Martinell, E Giralt, J Gil, ... British journal of pharmacology 131 (3), 585-593, 2000 | 312 | 2000 |
| Modulating protein–protein interactions: the potential of peptides L Nevola, E Giralt Chemical Communications 51 (16), 3302-3315, 2015 | 304 | 2015 |
| A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants O Taboga, C Tami, E Carrillo, JI Nunez, A Rodríguez, JC Saiz, E Blanco, ... Journal of virology 71 (4), 2606-2614, 1997 | 282 | 1997 |
| Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity D Kalafatovic, E Giralt molecules 22 (11), 1929, 2017 | 274 | 2017 |
| Piperidine: structure, preparation, reactivity, and synthetic applications of piperidine and its derivatives M Rubiralta, E Giralt, A Diez Elsevier, 2013 | 272 | 2013 |
| Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly S Pujals, J Fernández-Carneado, C López-Iglesias, MJ Kogan, E Giralt Biochimica et biophysica acta (BBA)-biomembranes 1758 (3), 264-279, 2006 | 257 | 2006 |
| Proline-rich, amphipathic cell-penetrating peptides S Pujals, E Giralt Advanced drug delivery reviews 60 (4-5), 473-484, 2008 | 251 | 2008 |
| A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C MG Mateu, MA Martinez, L Capucci, D Andreu, E Giralt, F Sobrino, ... Journal of General Virology 71 (3), 629-637, 1990 | 242 | 1990 |
Marcelo J KoganProfessor, Universidad de Chile, Advanced Center for Chronic Diseases (ACCDiS)Verified email at ciq.uchile.cl
